Condensed Consolidated Statements of Cash Flows (USD $)	9 Months Ended		64 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013
Cash Flows from Operating Activities
Net Loss	$ (4,491,868)	$ (1,696,899)	$ (10,503,411)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	2,877	2,332	6,088
Amortization of debt issuance costs	28,229	56,327	126,742
Re-measurement of fair value of stock warrants liability	122,202	(4,240)	126,782
Non-cash consideration for rent			15,624
Stock based compensation	377,388	80,980	731,423
Increase (decrease) in cash arising from changes in assets and liabilities:
Related party receivable	(10,813)	(6,241)	(20,384)
Prepaid expenses and other current assets	(742,029)	(53,608)	(800,465)
Restricted cash	24,672	(24,485)	(1,542)
Deposits		200	(9,320)
Accounts payable	(112,943)	24,982	392,528
Accrued expenses and other payables	28,071	63,481	157,279
Accrued interest	8,387	3,790	73,421
Net Cash Used by Operating Activities	(4,765,827)	(1,553,381)	(9,705,235)
Cash Flows from Investing Activities
Purchase of property and equipment	(5,194)	(1,780)	(19,187)
Net Cash Used in Investing Activities	(5,194)	(1,780)	(19,187)
Cash Flows from Financing Activities
Proceeds from initial public offering, net of underwriting discounts	25,110,000		25,110,000
Borrowings on notes payable		650,000	950,000
Borrowings on line of credit		80,204	273,427
Payments on notes payable	(725,000)	(225,000)	(950,000)
Payments on line of credit			(273,427)
Issuance of convertible notes payable, net of issuance costs	(197,099)		2,584,537
Issuance of common stock	540		12,330
Exercise of stock options	47,957		47,957
Stock issuance costs	(942,052)	(700)	(989,636)
Net Cash Provided by Financing Activities	28,344,436	1,587,838	33,302,867
Net Increase in Cash and Cash Equivalents	23,573,415	32,677	23,578,445
Cash and Cash Equivalents - Beginning of Period	5,030	98,646
Cash and Cash Equivalents - End of Period	23,578,445	131,323	23,578,445
Supplemental Disclosure for Cash Flow Information
Interest paid	51,575	16,773	126,259
Supplemental Schedule of Noncash Investing and Financing Activities
Beneficial conversion charge	2,300,000		2,300,000
Issuance of preferred stock warrants and debt issuance costs			87,570
Notes payable converted to Series A preferred stock			2,674,980
Conversion of convertible note payable to accounts payable	197,099		197,099
Cancellation of common stock			65
Non-cash consideration for rent			15,624
Non-cash conversion of preferred stock into common stock	386		386
Preferred stock dividend	361,668		361,668
Series A Preferred Stock [Member]
Cash Flows from Financing Activities
Issuance of preferred stock		1,083,334	1,487,589
Series B-1 Preferred Stock [Member]
Cash Flows from Financing Activities
Issuance of preferred stock	$ 5,050,090		$ 5,050,090